SEC Form 4Coverage since Jun 2, 2026
$NAUT insider trading
Over the last 12 months, Nautilus Biotechnology insiders reported no purchases and 2 sales totaling $11.8M across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $11.8M 2 events
- Events · 12m
- 2 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $NAUT · 12Mvia TradingView
Top insiders · 12m
AH Equity Partners Bio II, L.L.C.—2× · $11.8M
All insider trades
2 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | AH Equity Partners Bio II, L.L.C.10% | ▼ Sale | 384,026 | $2.35 | $902K | -28.3% | indirect |
| Jun 2, 2026 | AH Equity Partners Bio II, L.L.C.10% | ▼ Sale | 4,615,974 | $2.35 | $10.8M | -28.3% | indirect |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $NAUT feed.